Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.

PubWeight™: 5.97‹?› | Rank: Top 1%

🔗 View Article (PMID 11238697)

Published in J Natl Cancer Inst on March 07, 2001

Authors

B Rockhill1, D Spiegelman, C Byrne, D J Hunter, G A Colditz

Author Affiliations

1: B. Rockhill, C. Byrne, Channing Laboratory, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA. beverly.rockhill@channing.harvard.edu

Articles citing this

(truncated to the top 100)

Clinical practice. Mammographic screening for breast cancer. N Engl J Med (2003) 6.01

Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med (2008) 4.81

Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst (2008) 4.52

American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. J Clin Oncol (2009) 3.51

Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study. Ann Intern Med (2012) 3.45

Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med (2014) 3.09

Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model. J Natl Cancer Inst (2009) 3.04

Nomogram to predict the benefit of radiation for older patients with breast cancer treated with conservative surgery. J Clin Oncol (2012) 2.85

Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res (2007) 2.71

Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med (2015) 2.46

PancPRO: risk assessment for individuals with a family history of pancreatic cancer. J Clin Oncol (2007) 2.45

Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study. Eur Urol (2015) 2.41

Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst (2009) 2.35

Model for individualized prediction of breast cancer risk after a benign breast biopsy. J Clin Oncol (2015) 2.25

Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet (2003) 2.24

Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern Med (2014) 2.08

Assessment of the accuracy of the Gail model in women with atypical hyperplasia. J Clin Oncol (2008) 2.06

Risk prediction using genome-wide association studies. Genet Epidemiol (2010) 2.03

Risk factor modification and projections of absolute breast cancer risk. J Natl Cancer Inst (2011) 1.94

Hip bone density predicts breast cancer risk independently of Gail score: results from the Women's Health Initiative. Cancer (2008) 1.84

Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J Clin Oncol (2008) 1.59

A model for predicting the risk of de novo stress urinary incontinence in women undergoing pelvic organ prolapse surgery. Obstet Gynecol (2014) 1.52

Risk-benefit profiles of women using tamoxifen for chemoprevention. J Natl Cancer Inst (2014) 1.51

Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. J Natl Cancer Inst (2011) 1.51

Personalized estimates of breast cancer risk in clinical practice and public health. Stat Med (2011) 1.49

Validating and improving models for projecting the absolute risk of breast cancer. J Natl Cancer Inst (2001) 1.48

Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement. Breast Cancer Res (2012) 1.47

Validation of a breast cancer risk prediction model developed for Black women. J Natl Cancer Inst (2013) 1.46

Improving outcomes in breast cancer for low and middle income countries. World J Surg (2015) 1.39

Molecular targets for cancer chemoprevention. Nat Rev Drug Discov (2009) 1.38

Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. J Clin Oncol (2005) 1.37

Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." Dementia risk indices: A framework for identifying individuals with a high dementia risk. Alzheimers Dement (2010) 1.27

A framework for evaluating markers used to select patient treatment. Med Decis Making (2013) 1.25

Parenchymal texture analysis in digital breast tomosynthesis for breast cancer risk estimation: a preliminary study. Acad Radiol (2009) 1.24

Novel breast tissue feature strongly associated with risk of breast cancer. J Clin Oncol (2009) 1.23

A clinical risk prediction model for Barrett esophagus. Cancer Prev Res (Phila) (2012) 1.21

Breast percent density: estimation on digital mammograms and central tomosynthesis projections. Radiology (2009) 1.17

Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy. Cancer (2009) 1.16

Association of computerized mammographic parenchymal pattern measure with breast cancer risk: a pilot case-control study. Radiology (2011) 1.15

Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancers. J Clin Oncol (2012) 1.15

Risk prediction models with incomplete data with application to prediction of estrogen receptor-positive breast cancer: prospective data from the Nurses' Health Study. Breast Cancer Res (2008) 1.12

Breast cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology. J S C Med Assoc (2006) 1.10

Breast cancer risk and provider recommendation for mammography among recently unscreened women in the United States. J Gen Intern Med (2006) 1.06

Effect of changing breast cancer incidence rates on the calibration of the Gail model. J Clin Oncol (2010) 1.05

Risk models used to counsel women for breast and ovarian cancer: a guide for clinicians. Fam Cancer (2001) 1.05

A case-control study on risk factors of breast cancer in China. Arch Med Sci (2012) 1.04

Evaluating breast cancer risk projections for Hispanic women. Breast Cancer Res Treat (2011) 0.99

Evaluation of a breast cancer risk prediction model expanded to include category of prior benign breast disease lesion. Cancer (2010) 0.99

The relation between projected breast cancer risk, perceived cancer risk, and mammography use. Results from the National Health Interview Survey. J Gen Intern Med (2005) 0.98

Pathogenesis, prevention, diagnosis and treatment of breast cancer. World J Clin Oncol (2014) 0.98

Assessing participation in community-based physical activity programs in Brazil. Med Sci Sports Exerc (2014) 0.94

Postmenopausal hormone therapy: risks and benefits. Nat Rev Endocrinol (2013) 0.93

Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer. Fam Cancer (2012) 0.92

Gail model risk assessment and risk perceptions. J Behav Med (2004) 0.92

Triggering the landslide: The tumor-promotional effects of myofibroblasts. Exp Cell Res (2013) 0.92

Estrogen metabolism and exposure in a genotypic-phenotypic model for breast cancer risk prediction. Cancer Epidemiol Biomarkers Prev (2011) 0.90

Risk factors for second screen-detected or interval breast cancers in women with a personal history of breast cancer participating in mammography screening. Cancer Epidemiol Biomarkers Prev (2013) 0.90

Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women. Breast Cancer Res (2012) 0.90

Premenopausal serum androgens and breast cancer risk: a nested case-control study. Breast Cancer Res (2012) 0.89

Five-year and lifetime risk of breast cancer among U.S. subpopulations: implications for magnetic resonance imaging screening. Cancer Epidemiol Biomarkers Prev (2010) 0.88

Mammographic parenchymal patterns as an imaging marker of endogenous hormonal exposure: a preliminary study in a high-risk population. Acad Radiol (2013) 0.88

Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer. J Clin Oncol (2014) 0.88

Two-stage sampling designs for external validation of personal risk models. Stat Methods Med Res (2013) 0.87

Preliminary evaluation of the publicly available Laboratory for Breast Radiodensity Assessment (LIBRA) software tool: comparison of fully automated area and volumetric density measures in a case-control study with digital mammography. Breast Cancer Res (2015) 0.87

A multi-centre randomised trial comparing ultrasound vs mammography for screening breast cancer in high-risk Chinese women. Br J Cancer (2015) 0.86

Twenty-five years of breast cancer risk models and their applications. J Natl Cancer Inst (2015) 0.86

Risk factors for breast cancer in postmenopausal Caucasian and Chinese-Canadian women. Breast Cancer Res (2010) 0.84

Chemoprevention for Breast Cancer. Ann Surg Oncol (2015) 0.83

The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Disease. Sci Rep (2016) 0.82

Birth weight, breast cancer and the potential mediating hormonal environment. PLoS One (2012) 0.82

Breast density and parenchymal texture measures as potential risk factors for Estrogen-Receptor positive breast cancer. Proc SPIE Int Soc Opt Eng (2014) 0.82

Estrogen exposure, metabolism, and enzyme variants in a model for breast cancer risk prediction. Cancer Inform (2009) 0.82

Knowledge and accuracy of perceived personal risk in underserved women who are at increased risk of breast cancer. J Cancer Educ (2010) 0.82

A focus group study on breast cancer risk presentation: one format does not fit all. Eur J Hum Genet (2012) 0.82

A randomized trial of three videos that differ in the framing of information about mammography in women 40 to 49 years old. J Gen Intern Med (2003) 0.82

The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms. Breast Cancer Res (2015) 0.81

Assessing individual risk for high-risk colorectal adenoma at first-time screening colonoscopy. Int J Cancer (2015) 0.81

Breast cancer risk prediction and mammography biopsy decisions: a model-based study. Am J Prev Med (2013) 0.81

Vascular endothelial growth factor and breast cancer risk. Cancer Causes Control (2008) 0.81

Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort study. Breast Cancer Res Treat (2013) 0.80

Searching for blood DNA methylation markers of breast cancer risk and early detection. J Natl Cancer Inst (2013) 0.80

Using Intensive Longitudinal Data Collected via Mobile Phone to Detect Imminent Lapse in Smokers Undergoing a Scheduled Quit Attempt. J Med Internet Res (2016) 0.79

Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: A randomized, controlled trial. Breast (2015) 0.79

Performance of the Breast Cancer Risk Assessment Tool Among Women Age 75 Years and Older. J Natl Cancer Inst (2015) 0.79

Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia. BMC Womens Health (2007) 0.79

Baseline mammographic breast density and the risk of invasive breast cancer in postmenopausal women participating in the NSABP study of tamoxifen and raloxifene (STAR). Cancer Prev Res (Phila) (2012) 0.79

The impact of covariate measurement error on risk prediction. Stat Med (2015) 0.79

Assessing risk of breast cancer in an ethnically South-East Asia population (results of a multiple ethnic groups study). BMC Cancer (2012) 0.78

New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer risk. Arch Intern Med (2009) 0.78

Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility. BMC Med Genomics (2015) 0.78

Computational Discrimination of Breast Cancer for Korean Women Based on Epidemiologic Data Only. J Korean Med Sci (2015) 0.78

Impact of breast cancer on African American women: priority areas for research in the next decade. Am J Public Health (2002) 0.77

Validation of risk assessment models for predicting the incidence of breast cancer in korean women. J Breast Cancer (2014) 0.77

Utility of relative and absolute measures of mammographic density vs clinical risk factors in evaluating breast cancer risk at time of screening mammography. Br J Radiol (2015) 0.76

Prospective approach to breast cancer risk prediction in African American women: the black women's health study model. J Clin Oncol (2015) 0.76

Validity assessment of the Breast Cancer Risk Reduction Health Belief scale. Cancer (2009) 0.76

Predictors of Non-Adherence to Breast Cancer Screening among Hospitalized Women. PLoS One (2015) 0.75

A steroid metabolizing gene variant in a polyfactorial model improves risk prediction in a high incidence breast cancer population. BBA Clin (2014) 0.75

Risk assessment model for invasive breast cancer in Hong Kong women. Medicine (Baltimore) (2016) 0.75

Objective and subjective breast cancer risk: relationships with natural killer cell activity and psychological distress in healthy women. Cancer Nurs (2010) 0.75

Articles by these authors

Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol (1992) 17.17

The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08

Body weight and mortality among women. N Engl J Med (1995) 11.04

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage (2008) 10.99

Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol (1989) 10.98

Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol (1986) 10.84

Validity of self-reported waist and hip circumferences in men and women. Epidemiology (1990) 10.57

Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet (1998) 10.11

Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol (1994) 9.90

Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc (1993) 9.90

Aspirin and the risk of colorectal cancer in women. N Engl J Med (1995) 9.59

Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol (1999) 9.34

Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med (1990) 8.98

No hiding place: on the discomforts of researching the contemporary policy process. J Soc Policy (1990) 8.97

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med (1991) 8.66

Prospective study of alcohol consumption and risk of coronary disease in men. Lancet (1991) 8.64

Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med (1997) 8.43

Evidence based policymaking. BMJ (1995) 8.08

Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet (1991) 7.87

OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage (2010) 7.52

Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA (1997) 7.42

A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol (1990) 7.24

Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care (1994) 7.11

Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA (1998) 7.09

Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med (2001) 7.07

Guidelines for healthy weight. N Engl J Med (1999) 7.03

Plasma organochlorine levels and the risk of breast cancer. N Engl J Med (1997) 7.02

Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA (1997) 6.92

The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med (2001) 6.37

Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med (1993) 6.37

Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med (2001) 6.23

Abdominal adiposity and coronary heart disease in women. JAMA (1998) 6.21

Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med (1999) 6.17

A prospective study of family history and the risk of colorectal cancer. N Engl J Med (1994) 6.12

A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med (1990) 6.06

Cost-effectiveness of screening for colorectal cancer in the general population. JAMA (2000) 5.88

Validation of a youth/adolescent food frequency questionnaire. Prev Med (1997) 5.78

Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr (2001) 5.67

Current estimates of the economic cost of obesity in the United States. Obes Res (1998) 5.52

Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med (1995) 5.42

Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med (1994) 5.42

Vitamin E consumption and the risk of coronary disease in women. N Engl J Med (1993) 5.39

Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst (2001) 5.33

Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. JAMA (1993) 5.31

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med (2000) 5.17

Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr (2000) 5.17

A prospective cohort study of vasectomy and prostate cancer in US men. JAMA (1993) 5.09

Correction of logistic regression relative risk estimates and confidence intervals for systematic within-person measurement error. Stat Med (1989) 5.08

Birthweight as a risk factor for breast cancer. Lancet (1996) 5.05

Intake of trans fatty acids and risk of coronary heart disease among women. Lancet (1993) 5.00

Postmenopausal hormone therapy and mortality. N Engl J Med (1997) 4.96

Television viewing as a cause of increasing obesity among children in the United States, 1986-1990. Arch Pediatr Adolesc Med (1996) 4.91

Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol (1997) 4.84

A random-effects regression model for meta-analysis. Stat Med (1995) 4.83

Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83

Dual effects of weight and weight gain on breast cancer risk. JAMA (1997) 4.81

Correction of logistic regression relative risk estimates and confidence intervals for measurement error: the case of multiple covariates measured with error. Am J Epidemiol (1990) 4.80

Dietary fat and fiber in relation to risk of breast cancer. An 8-year follow-up. JAMA (1992) 4.80

Risk of overweight among adolescents who were breastfed as infants. JAMA (2001) 4.80

Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA (1995) 4.78

Use of statistical analysis in the New England Journal of Medicine. N Engl J Med (1983) 4.76

Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (1998) 4.74

Menopause and the risk of coronary heart disease in women. N Engl J Med (1987) 4.70

Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA (1998) 4.65

A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med (1999) 4.61

A prospective study of passive smoking and coronary heart disease. Circulation (1997) 4.51

A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA (1997) 4.50

Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. BMJ (1997) 4.49

Birthweight and the risk for type 2 diabetes mellitus in adult women. Ann Intern Med (1999) 4.49

Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care (1997) 4.46

Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA (1999) 4.43

Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals. Epidemiology (1996) 4.37

Smoking cessation and decreased risk of stroke in women. JAMA (1993) 4.36

OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage (2007) 4.34

Ontario Child Health Study. II. Six-month prevalence of disorder and rates of service utilization. Arch Gen Psychiatry (1987) 4.30

Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA (2001) 4.30

Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA (1996) 4.29